Dora S.V., Khalimov Yu.Sh., Mekhtiev S.N., Lisker A.V., Zimina M.V., Semikova G.V., Volkova A.R., Cherebillo I.V., Polyakova Yu.V.
Correlation between estrogen deficiency and non-alcoholic fatty liver disease in female patients
|
№8 / 2024
|
Davidenko I.Yu., Sorokina Yu.A., Volkova N.I., Degtyareva Yu.S., Kovalenko V.N., Golubev M.E.
Peculiarities of nutrition in pregnant females with different subtypes of gestational diabetes mellitus
|
№9 / 2023
|
|
№3 (приложение) / 2023
|
|
№3 (приложение) / 2023
|
Volkova N.I., Davidenko I.Yu., Sorokina Yu.A., Degtyareva Yu.S.
Risk factors for the development of various subtypes of gestational diabetes mellitus
|
№10 / 2022
|
Anikin D.A., Solovieva I.A., Demko I.V., Sobko E.A., Gordeeva N.V., Kraposhina A.Yu.
Peculiarities of the association of bronchial asthma with obesity depending on the time of asthma debut and the possibilities of cardiovascular risk prediction in this group of patients
|
№10 / 2022
|
Gosteva E.V., Vasilyeva L.V., Suslova E.Yu., Inshakova K.Yu.
Association of cardiovascular risk factors and vitamin D status in patients with metabolic syndrome
|
№4 (приложение) / 2022
|
Alieva A.M., Baykova I.E., Khadzhieva N.H., Ettinger O.A., Arakelyan R.А., Valiev R.K., Rakhaev A.M., Batov М.А., Elmurzaeva D.А., Malkarova D.S., Nikitin I.G.
Resistin and cardiovascular pathology
|
№9 / 2021
|
Shishkova V.N., Martynov A.I.
Modern opportunities of therapy for metabolic cardiomyopathy and heart failure
|
№6 / 2020
|
O.A. Gromova, I.Yu. Torshin, V.F. Zgoda, I.К. Tomilova
Molecular mechanisms of action of Laennec against development of metabolic syndrome and obesity
|
№5 / 2017
|
A.R. Volkova, E.N. Ostroukhova, O.D. Dygun, L.A. Belyakova, K.V. Krasnyuk, V.S. Sidelnikova
Glucose toxicity and peripheral insulin resistance in patients with type 2 diabetes: the way to overcome
|
№5 / 2017
|
T.Yu. Demidova, D.V. Skuridina, Ya.V. Pugovkina
Targets and modern strategy of therapy for different groups of patients with type 2 diabetes mellitus
|
№5 / 2017
|